Fondazione IRCCS INT - Milano

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Sarcoma5 trials
• Colorectal cancer2 trials
• Childhood cancers1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Not yet recruiting2 trials
• Recruiting2 trials
• Completed1 trial
• Suspended1 trial
• Withdrawn1 trial

Lead sponsor

• Italian Sarcoma Group5 trials
• Gruppo Oncologico del Nord-Ovest2 trials

Running trials

• Recruiting

  FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

  NCT06733038· Phase 3· Gruppo Oncologico del Nord-Ovest· Source

  Contact: Filippo Pietrantonio, MD

• Recruiting

  Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

  NCT04383119· Phase 2· Italian Sarcoma Group· Source

  Contact: Roberta Sanfilippo, MD

• Recruiting

  Study on Clinical Features and Outcomes of Breast Sarcoma

  NCT04749446· Italian Sarcoma Group· Source

  Contact: Silvia Stacchiotti, MD

• Recruiting

  An Observational Study on Epithelioid Sarcoma

  NCT03099681· Italian Sarcoma Group· Source

  Contact: Paolo Casali, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sarcoma3 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting

Closed trials

• Completed

  Eribulin in Advanced Solitary Fibrous Tumor

  NCT03840772· Phase 2· Italian Sarcoma Group· Source

• Withdrawn

  Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin

  NCT03773510· Phase 3· Italian Sarcoma Group· Source